61.73

3.88% -2.49

After Hours: 61.86 0.13 +0.21%

Guardant Health Inc (GH)

Overview News Price History Option Chain Financials Why GH Down? Discussions Forecast

Guardant Health Inc stock is traded at $61.73, with a volume of 2.03M. It is down -3.88% in the last 24 hours and up +12.45% over the past month. Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Previous Close:

$64.22

Open:

$64.56

24h Volume:

2.03M

Relative Volume:

0.81

Market Cap:

$7.70B

Revenue:

$692.26M

Net Income/Loss:

$-512.41M

P/E Ratio:

-14.56

EPS:

-4.24

Net Cash Flow:

$-274.36M

1W Performance:

-2.60%

1M Performance:

+12.45%

6M Performance:

+41.23%

1Y Performance:

+188.46%

1-Day Range:

$61.33

$65.23

1-Week Range:

$61.33

$66.57

52-Week Range:

$20.14

$68.00

Guardant Health Inc Stock (GH) Company Profile

Name

Guardant Health Inc

Sector

Healthcare (1142)

Industry

Diagnostics & Research (52)

Phone

855-698-8887

Address

3100 HANOVER STREET, PALO ALTO

Employee

2,021

Twitter

@guardanthealth

Next Earnings Date

2024-11-06

Latest SEC Filings

GH's Discussions on Twitter

Compare GH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GH Guardant Health Inc	61.73	8.01B	692.26M	-512.41M	-274.36M	-4.24
TMO Thermo Fisher Scientific Inc	524.58	198.17B	43.21B	6.58B	6.17B	17.28
DHR Danaher Corp	205.14	144.97B	24.01B	3.41B	4.86B	4.7082
IDXX Idexx Laboratories Inc	633.32	49.29B	4.04B	985.66M	774.34M	12.01
A Agilent Technologies Inc	138.23	38.73B	6.79B	1.22B	1.09B	4.2644
IQV Iqvia Holdings Inc	203.77	33.69B	15.70B	1.24B	2.01B	6.9036

Guardant Health Inc Stock (GH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-25-25	Upgrade	Wolfe Research	Peer Perform → Outperform
Sep-22-25	Resumed	Wells Fargo	Overweight
Apr-10-25	Initiated	Mizuho	Outperform
Jan-23-25	Initiated	Barclays	Overweight
Jun-28-24	Upgrade	Guggenheim	Neutral → Buy
Jun-03-24	Resumed	Jefferies	Buy
Apr-24-24	Resumed	Craig Hallum	Buy
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-13-23	Upgrade	Raymond James	Mkt Perform → Outperform
Sep-28-23	Initiated	Bernstein	Outperform
Sep-27-23	Upgrade	Piper Sandler	Neutral → Overweight
Jul-05-23	Resumed	JP Morgan	Overweight
May-26-23	Upgrade	Citigroup	Neutral → Buy
May-05-23	Initiated	UBS	Buy
Mar-09-23	Downgrade	Citigroup	Buy → Neutral
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Nov-01-22	Downgrade	Piper Sandler	Overweight → Neutral
Oct-19-22	Initiated	Craig Hallum	Buy
Oct-06-22	Initiated	Stephens	Overweight
Aug-25-22	Initiated	Credit Suisse	Outperform
Jun-03-22	Initiated	Piper Sandler	Overweight
Apr-28-22	Resumed	BTIG Research	Buy
Feb-24-22	Reiterated	Canaccord Genuity	Buy
Feb-24-22	Reiterated	Citigroup	Buy
Feb-24-22	Reiterated	Cowen	Outperform
Feb-24-22	Reiterated	Morgan Stanley	Overweight
Feb-24-22	Reiterated	SVB Leerink	Outperform
Feb-24-22	Reiterated	Stifel	Buy
Feb-24-22	Reiterated	Wells Fargo	Overweight
Oct-15-21	Resumed	Cowen	Outperform
Jun-15-21	Initiated	Raymond James	Mkt Perform
Jun-03-21	Initiated	Goldman	Buy
May-25-21	Initiated	Wells Fargo	Overweight
Jan-11-21	Initiated	Stifel	Buy
Sep-09-20	Initiated	Morgan Stanley	Overweight
Jun-12-20	Initiated	BTIG Research	Buy
Feb-21-20	Initiated	Guggenheim	Buy
Jan-07-20	Initiated	Citigroup	Buy
Aug-07-19	Reiterated	Canaccord Genuity	Buy
Apr-16-19	Initiated	Canaccord Genuity	Buy
Apr-10-19	Upgrade	BofA/Merrill	Neutral → Buy
Feb-28-19	Reiterated	BofA/Merrill	Neutral
Oct-29-18	Initiated	BofA/Merrill	Neutral
Oct-29-18	Initiated	JP Morgan	Overweight
Oct-29-18	Initiated	William Blair	Outperform

View All

Guardant Health Inc Stock (GH) Latest News

11:27 AM

How to use Fibonacci retracement on Guardant Health Inc.Weekly Stock Analysis & Low Risk Growth Stock Ideas - newser.com

11:27 AM

09:30 AM

Can Guardant Health Inc. stock deliver consistent earnings growth2025 Price Momentum & Short-Term Swing Trade Alerts - newser.com

09:30 AM

09:11 AM

What institutional flow reveals about Guardant Health Inc.2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com

09:11 AM

Oct 12, 2025

What analysts say about Guardant Health Inc stockRisk-Reward Ratio Analysis & Best Stocks For Explosive Growth - earlytimes.in

Oct 12, 2025

Guardant Health, Inc. (NASDAQ:GH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Oct 12, 2025

Oct 10, 2025

How to track smart money flows in Guardant Health Inc.Weekly Gains Report & Daily Profit Focused Screening - newser.com

Oct 10, 2025

Using Ichimoku Cloud for Guardant Health Inc. technicals2025 Retail Activity & High Return Stock Watch Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025 - Yahoo Finance

Oct 09, 2025

CustomerThink - CustomerThink

Oct 09, 2025

Quantitative breakdown of Guardant Health Inc. recent movePortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com

Oct 09, 2025

Why Guardant Health Inc. (5GH) stock stays on top picksOptions Play & AI Powered Market Entry Strategies - newser.com

Oct 09, 2025

Pattern recognition hints at Guardant Health Inc. upsideTake Profit & Weekly High Conviction Trade Ideas - newser.com

Oct 09, 2025

Is Guardant Health Inc. building a consolidation base2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - newser.com

Oct 09, 2025

Abel Hall LLC Invests $202,000 in Guardant Health, Inc. $GH - MarketBeat

Oct 09, 2025

Published on: 2025-10-09 03:21:22 - newser.com

Oct 09, 2025

Guardant Health's (GH) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 08, 2025

What drives Guardant Health Inc 5GH stock priceAnalyst Downgrades & Market Volatility Strategies - earlytimes.in

Oct 08, 2025

Oct 07, 2025

Evercore ISI Group Raises Price Target for Guardant Health (GH) to $68 | GH Stock News - GuruFocus

Oct 07, 2025

Evercore ISI Raises Guardant Health (NASDAQ:GH) Price Target to $68.00 - MarketBeat

Oct 07, 2025

Oct 06, 2025

Liquid Biopsy for Early Cancer Detection and Monitoring - GlobeNewswire

Oct 06, 2025

Liquid Biopsy for Early Cancer Detection and Monitoring Market Report 2025-2033, with Profiles of GRAIL, AnchorDx, Burning Rock Biotech, Genecast, Guardant Health, Elypta, Freenome, and Oncimmune - Yahoo Finance

Oct 06, 2025

Is Guardant Health Inc. (5GH) stock dividend growth reliableTrade Performance Summary & AI Forecast for Swing Trade Picks - newser.com

Oct 06, 2025

Visualizing Guardant Health Inc. stock with heatmapsCPI Data & Weekly Return Optimization Plans - newser.com

Oct 06, 2025

What momentum shifts mean for Guardant Health Inc.Quarterly Market Review & Precise Trade Entry Recommendations - newser.com

Oct 06, 2025

Using economic indicators to assess Guardant Health Inc. potentialJuly 2025 Drop Watch & Smart Allocation Stock Reports - newser.com

Oct 06, 2025

Oct 05, 2025

Guardant Health Inc Stock Analysis and ForecastMarket Liquidity Analysis & Rapid Capital Trading Plans - earlytimes.in

Oct 05, 2025

Shareholders in Guardant Health (NASDAQ:GH) Are in the Red If They Invested Three Years Ago - 富途牛牛

Oct 05, 2025

Oct 03, 2025

Guardant Health gets FDA nod for Guardant360 CDx as a companion diagnostic - MSN

Oct 03, 2025

How FDA Approval of Guardant360 CDx as Companion Diagnostic Could Impact Guardant Health (GH) Investors - Yahoo Finance

Oct 03, 2025

Is Quest Diagnostics' (DGX) Shield Partnership Transforming Its Role in Preventive Health Innovation? - Yahoo Finance

Oct 03, 2025

How to use a screener to detect Guardant Health Inc. breakoutsTrade Risk Report & Smart Money Movement Alerts - newser.com

Oct 03, 2025

What Does the Market Think About Guardant Health Inc? - Sahm

Oct 03, 2025

Oct 02, 2025

Comparing Guardant Health Inc. in custom built stock radarsJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com

Oct 02, 2025

Risk adjusted return profile for Guardant Health Inc. analyzedMarket Sentiment Report & Daily Momentum Trading Reports - newser.com

Oct 02, 2025

Barclays Raises Price Target for Guardant Health (GH) to $70.00 | GH Stock News - GuruFocus

Oct 02, 2025

4,782 Shares in Guardant Health, Inc. $GH Purchased by Trivium Point Advisory LLC - MarketBeat

Oct 02, 2025

Oct 01, 2025

GCC Liquid Biopsy Market Forecast and Company Analysis - GlobeNewswire

Oct 01, 2025

GCC Liquid Biopsy Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Bio-Rad, Thermo Fisher Scientific, Johnson & Johnson, Guardant Health, QIAGEN, Sysmex - Yahoo Finance

Oct 01, 2025

Sicart Associates LLC Increases Stock Holdings in Guardant Health, Inc. $GH - MarketBeat

Oct 01, 2025

Sep 30, 2025